Phosphorylation mediated suppression of GSK3β promotes breast tumor initiation and metastasis, and reduced phosphorylation of GSK3β efficiently inhibit cancer stem cell-like phenotypes in breast cancer[36,37]. The gene discussed is GSK3B; the disease is breast carcinoma.